Acerus Pharma Stock Price (OTCMKTS:TRLPF)

Add to My Stocks
$0.21 $0 (0%) TRLPF stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0.21
Market Cap:
Day Low: $0.21
52 Week Low: $0.08
Open: $0.21
Volume: -
Day High: $0.21
52 Week High: $0.40

Latest Stock Market News

Latest Articles

Acerus Pharma News - From Partners

TRLPF Stockcharts

View TRLPF PE ratio, PS ratio stocks charts and compare with peers.
Note: Compare Acerus Pharma stock price history with the index and industry peers.

Acerus Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Acerus Pharma Returns

(return on equity)

Acerus Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

TRLPF Industry Peers

Company Price Change (%)
Matinas Biopharma (MTNB)0.420 (0%)
Onconova Therapeutics (ONTX)0.50.01 (2.04%)
Generex Biotech (GNBT)1.970.06 (3.14%)
Antares Pharma (ATRS)3.360.21 (6.67%)
Palatin Technologies (PTN)1.020.03 (2.86%)
Sernova Corp (SEOVF)0.140 (0%)
Mannkind (MNKD)1.730.02 (1.17%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Acerus Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues6.44M24.48M16.91M4.31M-
Net Income-8.71M11.11M-9.03M-22.64M-31.95M
Total Operating Expense10.12M7.06M22.86M14.5M32.57M
View Acerus Pharma income statement
balance sheet20172016201520142013
Total Assets22.25M29.71M29.57M75.94M28.12M
Total Liabilities16.33M17.51M32.03M59.48M14.54M
Shareholders Equity5.91M12.2M-2.45M16.46M13.57M
View Acerus Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities5.68M5.5M-1.91M25.5M2.17M
Net Cash from (used by) Operating Activities-3.21M-1.02M8.43M-27.47M
Increase (Decrease) in Prop Plant And Equipment--0.07M-0.68M-0.21M-0.88M
View Acerus Pharma cash flow statement

Acerus Pharma Stock Message Board

An investor needs to spend $0.21 to buy TRLPF stock, as the closing Acerus Pharma stock price is $0.21. Looking at Acerus Pharma market capitalization, which currently stands at $49.4M, we can say that TRLPF stock is a Nano Cap stock. Acerus Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Acerus Pharma is worth a lot, it will most likely be reflected in an inflated Acerus Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 3,505 TRLPF shares were traded yesterday, and Acerus Pharma stock chart shows that the TRLPF stock quote hit a day high of $0.21 and day low of $0.21. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Acerus Pharma does not pay dividends. Acerus Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.